HEPATOCELLULAR

作品数：1273被引量：7979H指数：37
导出分析报告
相关领域：医药卫生更多>>
相关作者：张福君张亮吴沛宏顾仰葵赵明更多>>
相关机构：第二军医大学中山大学中国人民解放军总医院广州军区广州总医院更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划中国博士后科学基金广东省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Journal of Cancer Therapyx
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis被引量：1
《Journal of Cancer Therapy》2020年第3期115-123,共9页Junyi Shi Ai Shen Tong Mou Zhongjun Wu 
The prognosis of hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is very poor although sorafenib is recommended as the first-line treatment. Therefore, an effective treatment regime is needed f...
关键词：HEPATOCELLULAR Carcinoma PORTAL VEIN Tumor THROMBOSIS Hepatic ARTERIAL INFUSION Chemotherapy 
Intravoxel Incoherent Motion Diffusion Weighted Imaging for the Therapeutic Response of Transarterial Chemoembolization for Hepatocellular Carcinoma被引量：3
《Journal of Cancer Therapy》2019年第7期591-601,共11页Juan Peng Cui Yang Jing Zheng Ran Wang Yi Zhou Weicheng Wang Lin Yang Xiaoming Zhang Nandong Miao Yongjun Ren Hao Xu Xuli Min 
Background: Intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) can not only observe the diffusion of tissue water molecules but also reflect the blood perfusion information of tissue microcirculation. ...
关键词：HEPATOCELLULAR CARCINOMA DIFFUSION-WEIGHTED Imaging Intravoxel INCOHERENT Motion Transarterial CHEMOEMBOLIZATION 
Epidemiologic and Clinicopathologic Features of Advanced Hepatocellular Carcinoma
《Journal of Cancer Therapy》2019年第6期411-421,共11页Maha L. Zamzam 
Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide as well as in Egypt where it constitutes a significant public health problem. HCC is the third most common cause of death...
关键词：HEPATOCELLULAR Carcinoma EPIDEMIOLOGIC CLINICOPATHOLOGIC SURVIVAL 
Prognostic Factors for Hepatocellular Carcinoma: 5 Years’ Experience at the National Cancer Institute: A Retrospective Cohort Study
《Journal of Cancer Therapy》2018年第5期388-401,共14页Hussein O. Soliman Ahmed O. Touny Reda H. Tabashy Mohamed M. Abou El Moaty 
Background: Hepatocellular carcinoma is a great problem that poses a huge burden upon any healthcare system. In Egypt it has shown a doubling in its incidence rate. This study intended to assess the different prognost...
关键词：PROGNOSTIC Factors HEPATOCELLULAR Cancer HCV AFP EGYPT 
Role of lncRNAs in GI Cancer
《Journal of Cancer Therapy》2018年第3期281-298,共18页Murali Krishna Anju Mullath 
lncRNAs forms a part of the non coding part of human genome. This term denotes specific non coding RNAs with nucleotide length more than 200. They have been shown to affect various physiological and pathological proce...
关键词：lncRNA CANCER PANCREATIC GASTRIC HEPATOCELLULAR COLORECTAL 
Management of Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Using Three-Dimensional Conformal Radiotherapy
《Journal of Cancer Therapy》2017年第6期579-590,共12页Ahmed Abo Gabal Mohamed Lotayef Hoda Abd Elbaky Maha Hassan Heba Elzawahry Ekram Hamed 
Objective: To determine the possible therapeutic gain of using three-dimensional conformal radiotherapy (3D-CRT) as a treatment option for portal vein tumor thrombus (PVTT) in patients with hepatocellular carcinoma (H...
关键词：HEPATOCELLULAR Carcinoma PORTAL VEIN THROMBOSIS 3D CONFORMAL Radiotherapy PORTAL VEIN Tumor THROMBUS 
Rare Metastatic Lesion Affecting the Mouth: Case Report and Review
《Journal of Cancer Therapy》2017年第4期399-404,共6页Marcos Martins Curi Cláudia Curra Anthony Froy Benites Condezo Maria Flávia M. Rodrigues Mariane Pexe Bruna Moraes Carlos César DeAntoni Rosenvaldo Moreira Camila Lopes Cardoso 
The presence of metastases in the oral cavity is considered quietly rare in the literature. Considering metastasis of hepatocellular carcinoma, the occurrence occurs in approximately 1% of cases. The objective of this...
关键词：METASTASIS in the Oral Cavity HEPATOCELLULAR Carcinoma 
Role of Tyro3, Axl, and Mer Receptors and Their Ligands (Gas6, and Protein S) in Patients with Hepatocellular Carcinoma
《Journal of Cancer Therapy》2017年第2期112-130,共19页Soichiro Uehara Yuichi Fukuzawa Tomohiko Matuyama Katuhiro Gotoh 
The Tyro3, Axl and Mer (TAM) receptor tyrosine kinases are activated by endogenous ligands, protein S1 (PROS1) and growth arrest-specific gene 6 (Gas6), and those have important effects on cell biology. These receptor...
关键词：Tyro3 AXL MER GAS6 Protein S HEPATOCELLULAR Carcinoma 
Use of Initial Modified RECIST Tumor Response Evaluation Criteria for Predicting Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization with Drug-Eluting Beads被引量：2
《Journal of Cancer Therapy》2015年第13期1115-1123,共9页Natália Sousa Freitas Queiroz Luciana Kikuchi Regis Otaviano Franca Bezerra Regiane S. S. M. Alencar Aline Lopes Chagas Cláudia Megumi Tani Márcio Augusto Diniz Aline Cristine Barbosa Santos Airton Mota Moreira Manoel de Souza Rocha Luiz Augusto Carneiro D’Albuquerque Francisco César Carnevale Flair José Carrilho 
Introduction: Transarterial chemoembolization (TACE) reduces tumor growth and increases survival in patients with hepatocellular carcinoma (HCC). Drug-eluting beads (DEB) deliver slow-release chemotherapy and reduce s...
关键词：HEPATOCELLULAR Carcinoma mRECIST Criteria Transarterial CHEMOEMBOLIZATION Overall SURVIVAL DRUG-ELUTING BEADS 
Sorafenib after Arterial Chemoembolization in Child-Pugh A and B Cirrhotic Patients with Intermediate Hepatocellular Carcinoma: A Retrospective Analysis
《Journal of Cancer Therapy》2015年第3期286-292,共7页Fernando Gomes Romeiro Luciana Yumi Odani Sigahi Matheus Alvarez Fabio da Silva Yamashiro Fábio Cardoso de Carvalho Leonardo Pelafsky Talles Bazeia Lima Letícia de Campos Franzoni José Ricardo de Arruda Miranda Giovanni Faria Silva 
Introduction: Hepatocellular carcinoma (HCC) is a leading cause of mortality among cirrhotic patients, and current guidelines recommend single-treatment modalities according to patient and liver disease classification...
关键词：HEPATOCELLULAR Carcinoma CIRRHOSIS Arterial CHEMOEMBOLIZATION SORAFENIB 
全选清除导出
共3页<123>
检索报告 对象比较 聚类工具 使用帮助 返回顶部